AT&T: DirecTV Now Passes Proof Of Concept Seeking

New Post Public Reply Private Reply Replies (0) Message Board
chessmite
389
AT&T: DirecTV Now Passes Proof Of Concept
Seeking Alpha
Anthony Ruben





Summary


•DirecTV Now passed proof of concept by signing 200,000 customers in one month.

•Sling took about a year to achieve to achieve 600,000 customers.

•AT&T is creating an ecosystem with wireless, content delivery and content.


Last week, AT&T (NYSE:T) reported that its DirecTV Now service had achieved more than 200,000 paid subscribers in its first month of service. I consider this to be a huge win for T and an early signal that its diversified content delivery strategy will be successful.

Click to enlarge

Some myopic observers have focused on DirecTV Now's early streaming and customer service issues. As a user, I admit the service launch has been less than perfect. That is beside the point. The real point is customers have demonstrated they are ready, willing and able to switch from traditional content delivery to AT&T's streaming service. And switch in unheard of volumes. By comparison, the Wall Street Journal noted Sling TV (from DISH Network (NASDAQ ISH)) signed around 600,000 subscribers in its first year of service.

Now that the "proof of concept" period has passed, T will inevitably make the service less buggy (remember voice quality issues when using cell phones several years ago), improve customer service and focus on rapidly expanding customer acquisition volumes. DirecTV Now will, to a certain extent, be competing against Sling and Hulu, but the real competition will be against the legacy cable companies as well as the "Big Brother" DirecTV service. As evidenced by angst at Disney (NYSE IS) over declining ESPN revenues, consumers are in the early stages of a revolt against expensive, traditionally delivered content. Consumers are seeking the opportunity to view content anywhere, anytime on anything.


The big picture is T's creation of an ecosystem. Wireless is the center; the means of accessing data, content and communication. Content can be accessed in a consumer-friendly way, whether in a more robust traditional DirecTV platform or in the less expensive, more versatile DirecTV Now platform. And content itself will be created by Time Warner (HBO, CNN and Warner Brothers) or perhaps another provider if the merger is rejected. The more T can offer, the more value it can create in bundles, the lower future churn will be and the more value the Company can create for its shareholders. In the medium term, with 5G technology, T (and Verizon (NYSE:VZ)) will be able to displace the provider of home internet, which in many ways is the fulcrum of today's cable customer.

From an investment perspective, an ecosystem allows T to be more than simply the provider of a commodity product (wireless). An ecosystem allows for sales synergies (already being seen post-DirecTV acquisition) which 1) improve net dollar margins and 2) make it easier to say "yes" and harder to switch. For the past 15 years, cable providers have been pushing the "bundle" to create a communications ecosystem, and largely displaced fixed-wire landlines in the process. What T (and VZ) are moving toward is essentially a next-generation bundle.

From a valuation perspective, a commodity purveyor of a necessity is valued almost exclusively on its dividend. A firm that adds value, by having an ecosystem (and unique content/delivery capabilities) is more valuable. The value differential in today's low interest rate environment is likely +/- 20%. In a higher interest rate environment, the value differential may be greater. In 2016, as both T and VZ made moves into content, investors witnessed the market beginning to value these firms as more than dominant market share holders of commodity products.

Personally, I am sticking with DirecTV Now, warts and all, because it is less expensive than cable and it allows me to view content wherever I am. If I had not been so fed up with the arrogant behavior and obnoxious pricing of my legacy carrier, perhaps I would be more critical of launch bugs. However, I get the big picture and T will get my subscription dollars.
http://seekingalpha.com/article/4038995-t-dir...p;uprof=45

......still watching

Digital Uts Ventures (DUTV) Stock Research Links

DUTV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 316

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 0

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 406

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Stretch Zone Expands Horizons with Canadian Studio Launch

Updated Category News Views 214

Stretch Zone's Exciting New Chapter in Canada Stretch Zone, a trailblazer in the realm of assisted stretching, has embarked on a significant milestone by opening its first studio in Canada. This new location is not just a store but a powerful symbol of the brand's commitment to enhance flexibility and mobility in communities beyond the United States. The Vision Behind the...

Continue Reading
Eilean Therapeutics Unveils Groundbreaking JAK2 Inhibitor ZE74-0282

Updated Category News Views 585

New Frontiers in JAK2 Inhibition by Eilean Therapeutics Eilean Therapeutics LLC, a pioneering biotechnology company, is set to make waves in cancer treatment with its latest development, ZE74-0282, a wild-type-sparing JAK2-JH2/V617F inhibitor. The company has announced an exciting presentation at the upcoming American Society of Hematology (ASH) Annual Meeting, focusing...

Continue Reading
PodcastOne Extends LadyGang Contract as It Approaches 1000 Episodes

Updated Category News Views 116

PodcastOne Renews its Agreement with LadyGang Podcast PodcastOne, a key player in the podcasting world, is thrilled to announce the renewal of its contract with the immensely popular LadyGang podcast, hosted by Keltie Knight, Becca Tobin, and Jac Vanek. Launched in 2015 on PodcastOne, this engaging podcast has resonated with millions of listeners and is gearing up to...

Continue Reading
BCA Research Warns Upcoming Rate Cuts May Be Insufficient

Updated Category News Views 73

BCA Research Warns Rate Cuts May Arrive Too Late BCA Research has expressed concerns about the upcoming rate cuts, suggesting they might not effectively address a potential recession. The firm points out that the effects of monetary policy often lag, meaning the economy is still grappling with the repercussions of previous tightening measures. Market Sentiments and...

Continue Reading
SOMOS Pilates Nashville: A Vibrant Rebranding Journey

Updated Category News Views 235

SOMOS Pilates Nashville: A Vibrant Rebranding Journey In an inspiring shift, Studio Pilates Nashville has announced its rebranding as SOMOS Pilates Nashville. This transition marks a significant evolution, aimed at celebrating the studio's growth and commitment to community-centered movement practices. Welcoming a New Identity The rebranding initiative reveals more than...

Continue Reading